Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,286
Closed -$405K 1333
2021
Q4
$405K Sell
5,286
-1,101
-17% -$97.1K 0.01% 922
2021
Q3
$614K Sell
6,387
-1,448
-18% -$158K 0.01% 796
2021
Q2
$836K Buy
7,835
+2,444
+45% +$241K 0.01% 722
2021
Q1
$483K Sell
5,391
-1,773
-25% -$195K 0.01% 852
2020
Q4
$720K Sell
7,164
-3,044
-30% -$227K 0.01% 683
2020
Q3
$499K Sell
10,208
-2,073
-17% -$99.5K 0.01% 734
2020
Q2
$502K Buy
+12,281
New +$353K 0.01% 701
2020
Q1
Sell
-9,410
Closed -$213K 1131
2019
Q4
$213K Buy
+9,410
New +$154K ﹤0.01% 996

Other funds holding CRNC

Stephens Inc's CRNC Position: Q1 2022 in Review

Stephens Inc sold out of Cerence (CRNC) in Q1 2022, closing a stake of 5,286 shares — an estimated $405K sold.

Stephens Inc first reported a position in CRNC in Q4 2019 and held it in 8 quarters. The position peaked at $836K in Q2 2021. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

  • Stephens Inc reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
  • Stephens Inc sold 5,286 Cerence shares in Q1 2022, an estimated $405K.
  • Stephens Inc first reported a position in Cerence in Q4 2019 and held it in 8 quarters.
  • Stephens Inc's Cerence position peaked at $836K in Q2 2021.
  • 286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on Stephens Inc's 13F filing for Q1 2022, filed 4 May 2022.